Sex‐specific control of central nervous system autoimmunity by p38 mitogen‐activated protein kinase signaling in myeloid cells. Issue 1 (January 2014)
- Record Type:
- Journal Article
- Title:
- Sex‐specific control of central nervous system autoimmunity by p38 mitogen‐activated protein kinase signaling in myeloid cells. Issue 1 (January 2014)
- Main Title:
- Sex‐specific control of central nervous system autoimmunity by p38 mitogen‐activated protein kinase signaling in myeloid cells
- Authors:
- Krementsov, Dimitry N.
Noubade, Rajkumar
Dragon, Julie A.
Otsu, Kinya
Rincon, Mercedes
Teuscher, Cory - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ana24020-sec-0001" sec-type="section"> <title>Objective</title> <p>Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), characterized by a global increasing incidence driven by relapsing–remitting disease in females. Investigators have described p38 mitogen‐activated protein kinase (MAPK) as a key regulator of inflammatory responses in autoimmunity, but its role in the sexual dimorphism in MS or MS models remains unexplored.</p> </sec> <sec id="ana24020-sec-0002" sec-type="section"> <title>Methods</title> <p>Toward this end, we used experimental autoimmune encephalomyelitis (EAE), the principal animal model of MS, combined with pharmacologic and genetic inhibition of p38 MAPK activity and transcriptomic analyses.</p> </sec> <sec id="ana24020-sec-0003" sec-type="section"> <title>Results</title> <p>Pharmacologic inhibition of p38 MAPK selectively ameliorated EAE in female mice. Conditional deletion studies demonstrated that p38α signaling in macrophages/myeloid cells, but not T cells or dendritic cells, mediated this sexual dimorphism, which was dependent on the presence of adult sex hormones. Analysis of CNS inflammatory infiltrates showed that female but not male mice lacking p38α in myeloid cells exhibited reduced immune cell activation compared with controls, whereas peripheral T‐cell priming was unaffected in both sexes.<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ana24020-sec-0001" sec-type="section"> <title>Objective</title> <p>Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), characterized by a global increasing incidence driven by relapsing–remitting disease in females. Investigators have described p38 mitogen‐activated protein kinase (MAPK) as a key regulator of inflammatory responses in autoimmunity, but its role in the sexual dimorphism in MS or MS models remains unexplored.</p> </sec> <sec id="ana24020-sec-0002" sec-type="section"> <title>Methods</title> <p>Toward this end, we used experimental autoimmune encephalomyelitis (EAE), the principal animal model of MS, combined with pharmacologic and genetic inhibition of p38 MAPK activity and transcriptomic analyses.</p> </sec> <sec id="ana24020-sec-0003" sec-type="section"> <title>Results</title> <p>Pharmacologic inhibition of p38 MAPK selectively ameliorated EAE in female mice. Conditional deletion studies demonstrated that p38α signaling in macrophages/myeloid cells, but not T cells or dendritic cells, mediated this sexual dimorphism, which was dependent on the presence of adult sex hormones. Analysis of CNS inflammatory infiltrates showed that female but not male mice lacking p38α in myeloid cells exhibited reduced immune cell activation compared with controls, whereas peripheral T‐cell priming was unaffected in both sexes. Transcriptomic analyses of myeloid cells revealed differences in p38α‐controlled transcripts comprising female‐ and male‐specific gene modules, with greater p38α dependence of proinflammatory gene expression in females.</p> </sec> <sec id="ana24020-sec-0004" sec-type="section"> <title>Interpretation</title> <p>Our findings demonstrate a key role for p38α in myeloid cells in CNS autoimmunity and uncover important molecular mechanisms underlying sex differences in disease pathogenesis. Taken together, our results suggest that the p38 MAPK signaling pathway represents a novel target for much needed disease‐modifying therapies for MS. Ann Neurol 2014;75:50–66</p> </sec> </abstract> … (more)
- Is Part Of:
- Annals of neurology. Volume 75:Issue 1(2014:Jan.)
- Journal:
- Annals of neurology
- Issue:
- Volume 75:Issue 1(2014:Jan.)
- Issue Display:
- Volume 75, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 75
- Issue:
- 1
- Issue Sort Value:
- 2014-0075-0001-0000
- Page Start:
- 50
- Page End:
- 66
- Publication Date:
- 2014-01
- Subjects:
- Neurology -- Periodicals
Pediatric neurology -- Periodicals
Nervous system -- Surgery -- Periodicals
616.8 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-8249 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/109668537 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/76507645 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ana.24020 ↗
- Languages:
- English
- ISSNs:
- 0364-5134
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1043.140000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3130.xml